Cargando…
COVID-19 associated Mucormycosis (CAM): Implications for perioperative physicians – A narrative review
Mucormycosis once considered a rare disease with an incidence of 0.005 to 1.7 per million, has become one of the greatest menaces during the coronavirus disease (COVID-19) pandemic. India alone has contributed to nearly 70% of the global caseload of COVID-associated mucormycosis (CAM) and it had eve...
Autores principales: | Gupta, Anju, Kayarat, Bhavana, Gupta, Nishkarsh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077799/ https://www.ncbi.nlm.nih.gov/pubmed/37032681 http://dx.doi.org/10.4103/sja.sja_640_22 |
Ejemplares similares
-
Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
por: Kayarat, Bhavana, et al.
Publicado: (2021) -
Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19
por: Singh, Ravinder Pal, et al.
Publicado: (2021) -
Rationale for integration of palliative care in the medical intensive care: A narrative literature review
por: Gupta, Nishkarsh, et al.
Publicado: (2022) -
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM)
por: Osman, Nermin A., et al.
Publicado: (2023) -
COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?
por: Farias, Luís Arthur Brasil Gadelha, et al.
Publicado: (2021)